About The Cooper Companies, Inc. - Common Stock (COO)
Cooper Companies is a global medical device company that specializes in the design, manufacture, and marketing of innovative products in the eye care and women's health sectors. The company is best known for its extensive range of contact lenses, which cater to various needs including vision correction and lifestyle enhancements. Additionally, Cooper Companies offers a suite of women’s health products, particularly in the areas of fertility and other reproductive health solutions, aiming to improve the quality of life for individuals worldwide. Through its commitment to research and development, the company seeks to advance technology and provide high-quality, effective solutions for its customers. Read More
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Shares of medical device company CooperCompanies (NASDAQ:COO)
fell 15% in the afternoon session after the company reported underwhelming first-quarter 2025 results (fiscal Q2), with sales exceeding expectations by a whisker while organic sales growth guidance for the full year was lowered. Management called out "softening in two of its growth markets, contact lenses and fertility."
A strong May for U.S. equities is closing on a sour note, after President Donald Trump accused China of "totally" breaching a tariff agreement, raising new fears over trade disputes.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Friday as we examine the latest happenings in today's session.
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Friday. Stay informed about the latest market trends.
Medical device company CooperCompanies (NASDAQ:COO) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 6.3% year on year to $1 billion. The company expects the full year’s revenue to be around $4.13 billion, close to analysts’ estimates. Its non-GAAP profit of $0.96 per share was 3.3% above analysts’ consensus estimates.
SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025.
SAN RAMON, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (“Cooper”) (Nasdaq: COO), a leading medical device company, published its 2024 Sustainability Report. The report showcases the company’s initiatives to foster positive change for both people and the planet and provides expanded and updated sustainability performance data.
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 6.7%. This drop was discouraging since the S&P 500 held steady.
Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
SAN RAMON, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the William Blair Growth Stock Conference on Thursday, June 5, 2025. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 11:20 AM CT.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
SAN RAMON, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Barbara Carbone as an independent director, effective May 1, 2025. Ms. Carbone has also been appointed to serve on the Audit Committee when she joins the Board.
SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
